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http://www.biomedcentral.com/1472-6947/13/55RESEARCH ARTICLE Open AccessThe effectiveness of a graphical presentation in
addition to a frequency format in the context of
familial breast cancer risk communication: a
multicenter controlled trial
Lidewij Henneman1,4*, Jan C Oosterwijk2, Christi J van Asperen3, Fred H Menko4, Caroline F Ockhuysen-Vermey1,
Piet J Kostense5, Liesbeth Claassen1 and Daniëlle RM Timmermans1Abstract
Background: Inadequate understanding of risk among counselees is a common problem in familial cancer clinics.
It has been suggested that graphical displays can help counselees understand cancer risks and subsequent
decision-making. We evaluated the effects of a graphical presentation in addition to a frequency format on
counselees’ understanding, psychological well-being, and preventive intentions.
Design: Multicenter controlled trial.
Setting: Three familial cancer clinics in the Netherlands.
Methods: Participants: Unaffected women with a breast cancer family history (first-time attendees).
Intervention: Immediately after standard genetic counseling, an additional consultation by a trained risk counselor
took place where women were presented with their lifetime breast cancer risk in frequency format (X out of 100)
(n = 63) or frequency format plus graphical display (10 × 10 human icons) (n = 91).
Main outcome measures: understanding of risk (risk accuracy, risk perception), psychological well-being, and
intentions regarding cancer prevention. Measurements were assessed using questionnaires at baseline, 2-week and
6-month follow-up.
Results: Baseline participant characteristics did not differ between the two groups. In both groups there was an
increase in women’s risk accuracy from baseline to follow-up. No significant differences were found between
women who received the frequency format and those who received an additional graphical display in terms of
understanding, psychological well-being and intentions regarding cancer prevention. The groups did not differ in
their evaluation of the process of counseling.
Conclusion: Women’s personal risk estimation accuracy was generally high at baseline and the results suggest that
an additional graphical display does not lead to a significant benefit in terms of increasing understanding of risk,
psychological well-being and preventive intentions.
Trial registration: Current Controlled Trials ISRCTN14566836
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Risk communication in breast cancer genetic counseling
aims to improve women’s understanding of cancer risks
in order to facilitate informed decision-making [1]. The
risk communication concerns several risks, such as the
risk of having a hereditary form of breast cancer, i.e. a
BRCA1 or BRCA2 mutation. The cumulative lifetime can-
cer risk for carriers of a BRCA1/BRCA2 gene-mutation
is 60 to 80 percent [2,3], and these women are offered
management options including periodic screening and
prophylactic mastectomy. However, for most women with
a breast cancer family history the condition is due to en-
vironmental factors and low or medium penetrance genes,
most of which have not yet been identified. These women
have cancer risks that are only slightly or moderately
increased.
Several studies have shown that unaffected women with
a family history of breast cancer tend to overestimate
their breast cancer risk, even after genetic counseling, al-
though underestimation also occurs [4,5]. Inappropriate
(i.e. too high or too low) risk perceptions may lead to
potentially harmful behavior, for example overscreening (or
underscreening), in other words screening for breast cancer
that is more (or less) intensive than that recommended
based on actual risk [6,7]. Overestimation of risk may also
lead to breast cancer worry and negatively affect psycho-
logical well-being [8]. It is thus important to identify strat-
egies which will improve women’s understanding of risk.
It has been shown that the way in which risks are
presented may influence individuals’ interpretations of
risk and their subsequent decisions [9,10]. Risks can be
displayed in various presentation formats, such as num-
bers or words. Protocols in breast cancer genetic coun-
seling generally contain no guidelines for the optimal
format of risk communication. Research suggests that
clinical genetics professionals present risks in various
ways that differ from person to person in ways that seem
right to them, despite a lack of evidence to support their
methods [11].
People often find it difficult to understand risks, espe-
cially when risks are presented as numerical estimates
[12]. The use of (additional) graphical formats, such as
population icon arrays (i.e. a matrix of icons to visually
represent a population using different colors to indicate
the proportion of the population that would experience
the negative or positive outcome) and bar charts, is in-
creasingly popular for risk communication [13,14]. Graph-
ical displays may provide helpful support, in particular for
persons with low numeracy skills (the ability to under-
stand and use numbers) [15,16], and are appreciated by
patients [14,17]. Icon arrays allow the illustration of quan-
titative part-to-whole proportions and can counter fram-
ing effects and denominator neglect, since the size of the
population is taken into account [13,18,19]. The impact oficon arrays on actual perceptions and understanding
showed mixed results. On the one hand, researchers have
shown that risks presented as icon arrays did not result in
a better understanding, but did have a higher affective im-
pact and were perceived as higher compared to numerical
formats [9,20]. Visual formats may then be particularly
useful when the primary purpose of risk communication
is to increase awareness of risks. On the other hand, stud-
ies found that presenting risks in icon arrays resulted in a
lower perceived risk than when presenting information in
frequencies [16]. As icon arrays and other graphical pre-
sentations draw attention not only to the number of af-
fected people but also to those who are not affected,
making this information more salient [21], perceived risk
may be lower than for numerical risk information [16].
Although graphical displays are suggested to enhance
quantitative risk communication, empirical evidence from
clinical settings is scarce and few studies have been in the
form of controlled trials aimed at individuals at high can-
cer risk. In a prospective randomized controlled trial,
Ghosh et al. [22] showed that the use of icons arrays plus
bar chart improved the accuracy of risk perception in
breast cancer counseling. Most studies on risk presen-
tation formats that have been conducted are, however,
descriptive or were performed in a laboratory or experi-
mental setting with hypothetical scenarios and short-term
follow-up [16,23,24]. To translate these results into prac-
tice, more studies are needed involving counselees making
real-life decisions.
The main objective of this study was to evaluate the ef-
fect of a graphical risk communication format in addition
to a frequency format in genetic breast cancer counseling
with regard to the healthy counselees’ understanding of
risk (risk accuracy and perception of the risk), psycho-
logical well-being, and intentions regarding cancer pre-
vention. Based on the arguments discussed previously, it
was expected that graphical displays added to a frequen-
cy format were expected to lead to better understanding
[15,22], and to higher affective impact [9,20,23,25] com-
pared to a frequency format alone. The study was part of
the BRISC (Breast cancer RIsk Communication) study, a
prospective multicenter controlled trial to optimize the
communication of breast cancer risks in genetic counsel-
ing among women with a family history of breast cancer.
The study protocol has been published previously [26].
Methods
Study design and procedure
The BRISC study was designed as a controlled trial with
repeated measures using questionnaires. For the present
study, to analyze the effect of graphical presentation,
two presentations of lifetime risk information to women
were compared: frequency format vs. frequency format
plus a graphical display of risk. For the graphical display
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time-frame (age-related risk information) on outcome
measures – also part of the BRISC study – will be consid-
ered in future analyses, given that this was a different kind
of intervention where risks were not – or not only –
presented in a different format but also different risks
were presented. More details can be found elsewhere [26].
Sample
Power calculation indicated that 60 women per condi-
tion were needed to detect a clinically relevant difference
of 10-20% change in risk accuracy between the presenta-
tion formats [26]. Unaffected women with a breast can-
cer family history who were first-time attendees at the
familial cancer clinic were included. Women were re-
ferred to the clinical genetics departments if they fulfilled
the Dutch referral criteria [27]. Women were excluded if
they had a personal history of breast or ovarian cancer,
were under 18 years of age, had evident psychiatric illness
or terminal disease, or were unable to read and write
Dutch. Recruitment to participate took place between
December 2005 and November 2007 in three large DutchFigure 1 Example of graphical risk format. “On average, 10 out of every
their lifetime”.clinics: VU University Medical Center Amsterdam, Uni-
versity Medical Center Groningen, and Leiden University
Medical Center.
Intervention
Immediately after a standard genetic counseling session
with the clinical geneticist or genetic counselor (usual
care), an additional consultation by a trained risk counselor
took place in which risks were communicated in one of
two ways, namely: 1) in a frequency format (e.g. “On aver-
age, 10 out of every 100 women in the Netherlands will
develop breast cancer during their lifetime”); or 2) in a fre-
quency format plus a graphical display of risk (10×10
human figure icons) (see for example, Figure 1). Different
types of information were presented: absolute lifetime
breast cancer risk for an average woman (i.e. population
risk); breast cancer risk for women with BRCA1/BRCA2
mutation; the risk passing the mutated gene to children;
and the women’s personal breast cancer risk as based on
her family history.
After the risk consultation, which lasted approximately
30 minutes, all participants received a summary brochure100 women in the Netherlands will develop breast cancer during
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presented during the consultation.
Procedure
The Medical Ethics Committees of the participating
centers approved the protocol. Women were informed
by letter that the study was about different ways of
informing women about familial breast cancer but did
not mention that it was about risk communication. Par-
ticipants provided written informed consent before their
first visit. In each of the three centers participating, five
different risk formats were provided for 3–5 consecutive
months per center [26]. Women were allocated to one
of the conditions depending on the month they entered
the study. To correct for learning effect by the risk coun-
selors, the ranking order of each condition presented was
varied between the centers. In the current study, two of
the five risk conditions were compared (frequency format
and frequency format plus graphical display). Participants
received a questionnaire at home before their first ap-
pointment (baseline), two weeks after the risk consult-
ation, and six months after the risk consultation.
The genetic counselor estimated the counselees’ lifetime
breast cancer risk as part of standard genetic counseling.
Consensus was reached to standardize the content and
structure of the standard genetic counseling sessions prior
to the intervention by presenting the woman’s breast
cancer risk as risk group (i.e. ‘population risk’ (10%) or
one of three increased risk categories: ‘slightly increased’
(11-20%), ‘moderately increased’ (20-30%) or ‘highly in-
creased’ (30-40%)), using percentages when presenting
risks. The risk counselor was informed about the coun-
selees’ breast cancer risk by means of a “checklist after
standard counseling” that was filled out by the genetic
counselor. The checklist also included information on
whether the counselee or a relative had been offered DNA
testing. The study was blinded, i.e. the genetic counselors
did not know which group a woman was allocated to.Measures
Understanding of risk
With regard to understanding of risk, women’s risk ac-
curacy and risk perception was assessed. Risk accuracy
was measured with regard to two types of risks: 1) life-
time population breast cancer risk: a risk within plus or
minus 10% of the communicated risk was defined as ac-
curate, and 2) the woman’s own lifetime risk of getting
breast cancer as compared to the counseled risk: a risk
within their estimated risk category as provided by the
risk counselor was defined as accurate. For some women
the risk changed during the study due to the receipt of
genetic test results and in those women accuracy was
based on self-reported test results at 6-month follow-up.Risk perception was assessed using two items on a 7-
point rating scale: “How likely do you think it is that you
will get breast cancer during your lifetime” (very unlikely
(1) - very likely (7); ‘Perceived likeliness’), and “Based on
your feelings, how high is your lifetime risk of develop-
ing breast cancer” (very low (1) - very high (7); ‘Risk as
feeling’).
Psychological well-being
Psychological well-being was assessed using an adapted
version of the Lerman Cancer Worry Scale (CWS) (7
items, score range 7–28) [28], and the Dutch version of
the 6-item version of the State scale of the Spielberger
State-Trait Anxiety Inventory (STAI) (score range 6–24)
[29]. The scale reliability was good with a Cronbach’s
alpha of .93 for the CWS and .86 for the STAI.
Preventive intentions
Overscreening was addressed by looking at preventive in-
tentions at 6-month follow-up. Intentions with regard to
“having breast screening by a physician every 6 months”,
and “having a screening mammography every year” were
assessed on a 7-point scale (definitely not (1) to definitely
(7)). This was best assessable only in the subgroup with
lowest breast cancer risk (i.e. 10-20% risk) where this type
of preventive screening is not recommended according to
the Dutch guidelines, and thus low preventive intentions
were considered as required based on actual risk.
Evaluation of counseling process
The process of counseling as perceived by the women
was evaluated using the one-dimensional Dutch version
of the Perceived Personal Control questionnaire (PPC)
(α = .85) [30].
Other measures
Socio-demographic characteristics assessed included age,
level of education, marital status, number of children,
parents’ country of birth, religious activity, family history
of breast cancer, i.e. the number of family members that
have or have had breast cancer including the family re-
lationship. At 6-month follow-up, women were asked
about the results of DNA testing.
Statistical analyses
Comparisons of baseline characteristics between groups
were made using chi-square tests for categorical vari-
ables and t-tests for continuous variables. P-values less
than .05 were considered statistically significant. Char-
acteristics that differed at baseline between presenta-
tion formats were entered as covariates in the further
analyses. Logistic regression analyses were performed to
assess differences in the proportion of women with accur-
ate risk estimates (adjusted for pre-test (T0) risk accuracy)
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graphical display in risk accuracy at 2 weeks (T1) and 6
months (T2). Differences were reported with odds ratios
(ORs) and 95% confidence intervals (CIs). Analysis of co-
variance (ANCOVA) was performed to test the effects of
presentation format on perceived likeliness, risk as feel-
ings, psychological well-being, preventive intentions and
evaluation of counseling, by comparing pre-test- (T0)
with post-test- (T1/T2) outcome measures. Mean differ-
ences in outcomes scores between presentation formats
were reported with 95% CIs for significant differences.
Results
Response
Over a two-year period, 557 women (55% of the eligible
counselees) gave their informed consent. After consent,
110 women were excluded, mainly because they did not
meet the inclusion criteria or because they cancelled the
appointment for the additional risk consultation. An-
other 37 women were excluded after being allocated to
one of the additional risk presentation formats because
the data on risk estimation/category were not yet availableTable 1 Characteristics of the study population at baseline
Frequency format
N = 62





Married or cohabiting, n (%) 46 (74)
Number of children, mean (sd) 1.5 (1.5)
Ethnicity, n (%)
Both parents Dutch 55 (92)
Parent(s) not Dutch (Western) 3 (5)
Parent(s) not Western 2 (3)
(Very) actively religious, n (%) 16 (25)
Family history of breast cancer
# 1st degree relatives affected, mean (sd) 1.4 (0.7)
# 2nd degree relatives affected, mean (sd) 2.1 (1.1)
Women’s breast cancer risk estimationb, n (%)
Not/slightly increased (10-20%) 25 (40)
Moderately increased (20-30%) 21 (34)
Highly increased (30-40%) 16 (26)
aLow: primary school, lower level of secondary school, lower vocational training. Int
High: higher vocational training, university.
bAs estimated by the genetic counselor during standard genetic counseling before
population breast cancer risk in each group.
ct-test.
dChi2-test.
Sd = standard deviation.by the closure of the study. In total, 63 women received
a frequency format and 91 women received a frequency
format plus graphical display. The remaining 256 wom-
en received a different format (e.g. age-related risks), and
the corresponding effect of time-frame will be presented
elsewhere.
Baseline questionnaires were missing for one wom-
an in the frequency format group, and four women in
the frequency format plus graphical display group; these
women were excluded from the analyses, leaving 149
women in the analyses. Baseline demographic or other
participant characteristics did not differ between the two
groups (Table 1). Overall, 10.1% and 20.8% of the data
of participants were missing at 2-week- and 6-month
follow-up due to loss to follow-up, respectively. There
were no differences at baseline in outcome variables be-
tween participants with missing data at follow-up and
those for whom complete data were obtained.
At 6-month follow-up, 18 women in the frequency for-
mat group, and 23 women in the frequency format plus
graphical display group reported that they had received
DNA test results or were still waiting for their results.Frequency format + Graphical display Differences
N = 87 P-value


















ermediate: higher level of secondary school, intermediate vocational training.
risk consultation. Not/slightly increased risk group included two women with
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on the results of DNA testing. In total, seven women
reported that they had had a pathogenic mutation (true
positive results) after DNA testing for BRCA mutations
(lifetime risk changed to 60-80%), three of whom had
previously been informed that they had a slightly or
moderately increased risk. For five women in both the
frequency format group and the frequency format plus
graphical display group, the risk changed from moder-
ately or highly increased to a population risk of 10% due
to true negative test results. Five women with true nega-
tive results were already in the lowest risk group (i.e. risk
estimation did not change).
Understanding of risk
In both groups there was an overall increase in the
women’s accuracy of risk estimation from baseline to
follow-up. At 2-week- and 6-month follow-up, no differ-
ence in risk accuracy was found between women who re-
ceived the frequency format and those who received the
frequency format plus graphical display (Table 2). Results
did not change after excluding the women for whom the
risk had changed during the study due to the receipt of
genetic test results. Interestingly, in both groups, 74-79%
of women already had accurate perceptions of their own
breast cancer risk before standard genetic counseling.
Women who received the frequency format plus graphical
display had higher breast cancer risk perceptions, al-
though not significantly higher (F(1,108) =3.17, p = 0.07
for ‘Perceived likeliness’, and F(1,109) = 2.88, p = 0.08 for
‘Risk as feeling’), at 6-month follow-up compared with
women who received the frequency format only (Table 3).
Psychological well-being
Cancer-specific worry and state anxiety decreased over
time in both groups. No significant differences were
found between the risk format groups with regard to
women’s cancer worry (CWS) and STAI scores (Table 3).
Preventive intentions
For the subgroup of women with no or slightly increased










N = 62 N = 55 N =47 N =
Understanding of risk
Risk accuracy (% correct)
Population breast cancer risk 32 80 55 37
Women’s own breast cancer risk 79 88 89 74
OR = Odds ratio for frequency format + graphical display vs. frequency format only;the groups in behavioral intentions with regard to breast
cancer screening by physical examination or yearly mam-
mography (Table 3). In both groups, women were less in-
clined to have screening at 6-month follow-up compared
to baseline (on average from 6.6 to 4.8 - difference 95%
CI [1.14; 2.53] - for physical examination, and from 6.3 to
4.4 -difference 95% CI [1.10; 2.61] - for yearly mammog-
raphy). For yearly mammography, the difference between
baseline and follow-up was smaller, although not signifi-
cantly, in women who also received the graphical displays
(F(1,45) =3.16, p = 0.08).
Evaluation of counseling process
No significant differences were observed between scores
on PPC of women in the two groups (Table 3).
Discussion
This study investigated the effect of a graphical presenta-
tion format in addition to a frequency format among
healthy women with a family history of breast cancer
attending genetic counseling. There was an overall in-
crease in women’s accuracy of lifetime risk estimation
from baseline to follow-up. However, no significant dif-
ferences were found between the group who received
the frequency format compared to the group who re-
ceived the frequency format with a graphical display in
terms of understanding of risk, psychological well-being
and preventive intentions. No differences were found in
women’s evaluation of the counseling process.
The BRISC study is a field study; in other words, it is a
clinical trial which offers a unique opportunity to evalu-
ate effects of different formats of communicating risks
to counselees having to make real-life decisions. The
study was a multicenter trial encompassing three out of
nine Dutch familial cancer clinics. Women were allo-
cated to receiving a particular risk communication for-
mat depending on the time they entered the study. Not
only were the direct effects of communication assessed
but also the effects at 6-month follow-up. In interpreting
the results, one must, however, realize that any effect of
different formats for risk communication on people’s
perception and decision-making is bound to be small, innth follow-up, by intervention group







87 N =79 N =71 2-week 6-month
87 71 1.44 [.53; 3.92] 1.85 [.85; 4.06]
90 83 1.33 [.41; 4.37] .56 [.18; 1.72]
CI = confidence interval.
Table 3 Women’s understanding of risk, psychological well-being, preventive intentions and evaluation at baseline,
2-week and 6-month follow-up, by intervention group















N = 62 N = 55 N = 47 N = 87 N =79 N =71 2-week 6-month
Understanding of risk
Perceived likeliness (scale 1–7) 4.8 (1.1) 4.2 (1.5) 3.9 (1.4) 4.8 (1.3) 4.3 (1.3) 4.3 (1.5) .11 [−.42; .64] .46 [−.05; .97]
Risk as feeling (scale 1–7) 4.9 (1.6) 4.4 (1.7) 4.2 (1.7) 4.8 (1.6) 4.4 (1.7) 4.7 (1.6) .05 [−.48; .57] .50 [−.08; 1.08]
Psychological well-being
CWS (scale 7–28) 12.3 (3.8) 11.9 (2.9 11.6 (3.4) 13.2 (3.6) 12.7 (3.2) 12.2 (3.3) .07 [−.66; 81] .32 [−.97; 1.02]
STAI (scale 6–24) 10.0 (2.9) 9.5 (3.5) 9.3 (3.3) 10.7 (3.4) 10.2 (3.4) 9.6 (3.4) .39 [−.59; 1.37] .08 [−1.02; .85]
Preventive intentionsb
Breast screening by physician
(scale 1–7)
6.5 (0.9) 5.0 (2.4) 6.6 (0.8) 4.7 (2.7) -.24 [−1.69; 1.20]




19.1 (4.2) 20.1 (4.2) 19.4 (4.0) 18.3 (4.4) 19.9 (4.0) 19.9 (4.2) -.07 [−1.35; 1.32] .65 [−.85; 2.15]
aUnadjusted means and standard deviations (sd) are presented.
bData only presented for women in the lowest risk category (10-20%) at 6-month follow-up: n = 19 (frequency format) and n = 29 (frequency format and
graphical display).
CI = confidence interval.
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seling session before the risk communication consult-
ation (intervention) where the risks already had been
discussed. Moreover, the sample was powered to detect
a difference in risk accuracy. However, within each con-
dition women were already quite accurate with regard to
their own risk estimate leaving little room for improve-
ment in both groups. Furthermore, for some women in
both groups the risk status had changed as a result of
genetic testing, as one would expect to happen in real
life. In these cases, risk was based on the self-reported
test results, which might differ from their actual risk sta-
tus. For logistical reasons, actual test results were not
recorded in this study. Moreover, the study measured
women’s intentions to preventive behavior, and it is well
known that there is often a discrepancy between inten-
tions and actual behavior. Some caution should be taken
in generalizing the results to all women with familial
cancer since women with low education and women of
ethnic minority groups were underrepresented. It is well
known that in general women who come to the familial
cancer clinics are higher educated women and therefore
not representative for the whole population. Also, at 6
months, loss to follow-up was 25% and 22% of the
women in the frequency format and frequency format
plus graphical display group, respectively. To study dif-
ferences in preventive intentions, as we intended to do
for a small subgroup of women with low risk, a larger
sample is probably needed.This study showed no significant effects of an additional
graphical display to a frequency format on the outcome
measures. However, at 6-month follow-up, women who
received the additional graphical display had higher risk
perceptions, although not significantly higher, and, for
women in the lowest risk category, higher intentions to
have yearly mammography compared to women who re-
ceived the frequency format only. There is mixed evidence
regarding graphical displays improving understanding or
aiding decision-making [31]. Earlier studies did not find
an effect of population array displays on improved under-
standing, but did have a higher affective impact, with the
effect being perceived as larger compared to numerical
formats [9,20]. Numbers are shown to communicate more
detailed or precise informational aspects, whereas graph-
ical displays have sometimes been shown to better com-
municate the most significant message or gist (general
impression) [15,32]. It may be that in the present study,
the frequency format represented as additional graphical
information did not add to the accuracy of the under-
standing of the information already presented as numer-
ical frequencies. Hence an individual who understands the
frequency format may not need the additional graphic dis-
play to comprehend the information.
In this study, only icon arrays were evaluated, while
other graphical displays such as bar charts may also be
used. Waters et al. [24], for example, demonstrated that
bar graphs led to better understanding than numerical
risk information only. Bar charts may be particularly
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example, available to support shared decision-making
for women with high breast cancer risks [33]. Ghosh
et al. [22] found that breast cancer risk communication
using a graphical display (icons) accompanied by a bar
graph can improve short-term accuracy among women
who perceived very high risks (>50%). The question re-
mains as to whether adding a graphical display may have
adverse effects since it increases the quantity of informa-
tion and possibly also the overestimation of risks.
It has been shown that inadequate perception of risk
may lead to screening that is not consistent with the rec-
ommendations for their actual risk category [34]. The
present study showed that intentions regarding screen-
ing among women with a low to slightly increased breast
cancer risk actually decreased after counseling, and thus
were more in accordance with the guidelines, suggesting
that these women understood the consequences of their
risk more correctly after counseling.
Although risks are generally assumed to be important
for decision-making, the results suggest that the way in
which risks are presented does not influence women’s
intentions, either because the presentation format has
no effect on their understanding of the risks, or because
women do not consider risks important for their deci-
sions. For counselees, the risk level, in whatever form it
is presented, may be less relevant compared to other fac-
tors, e.g. emotions such as worry and pre-existing beliefs
[34]. It has also been argued that personal characteristics
such as cognitive ability and the ability to understand
graphs (graph literacy) may influence the perception and
comprehension of risks [19,35-37]. Future studies need
to consider who might or might not benefit from differ-
ent formats of health risks communication, and whether
certain formats may thereby overcome differences in
cognitive ability.
Up till now, in most studies, the majority of unaffected
women with a family history of breast cancer overestimated
their breast cancer risk [4,5]. In contrast, our study showed
that nearly eighty percent of women in both groups accur-
ately reported their breast cancer risk before standard gen-
etic counseling, leaving little room for improvement and
comparison between groups. The women seemed thus bet-
ter informed about their own risk than women in other
studies. One explanation may be the increasing attention
for (hereditary) breast cancer in the media in recent years
and the fact that more women and their families ask to be
referred for counseling, suggesting a higher current aware-
ness of familial risks. Nevertheless, some misunderstanding
of risk prevailed, for example only one third of women
could accurately report the population risk before counsel-
ing. An alternative explanation is the methodological dif-
ferences between studies, caused by a wide range of risk
accuracy measures [38]. A systematic review of the impactof genetic counseling on risk perception accuracy has
shown that accurate risk perception can be defined in
many different ways [4]. The authors of this review ar-
gued that risk perception accuracy should be defined as
correctly counseled risk (i.e. in accordance with the clini-
cian’s estimate). In the presented study, we have chosen
to define accuracy as falling within the correct risk cat-
egory, as this was how women’s own risk was actually
counseled during standard genetic counseling.
Conclusion
The results of this controlled trial suggest that a graph-
ical presentation in addition to a frequency format has
no effect on understanding of risks, psychological impact
and screening intentions. Further research is needed to
establish whether this is indeed the case.
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